HER-2 Negative Breast Cancer Market Hits an Outstanding CAGR Value of 10.1% During the Forecast Period 2023 to 2030

 

HER-2 Negative Breast Cancer Market

According to Coherent Market Insights, The global HER-2 Negative Breast Cancer Market was valued at US$ 12,647.0 Mn in 2022 and is forecast to reach a value of US$ 27,201.2 Mn by 2030 at a CAGR of 10.1% between 2023 and 2030.

The HER-2 negative subtype of breast cancer represents a significant portion of breast cancer cases worldwide. Over the years, advancements in technology have played a crucial role in shaping the diagnosis, treatment, and overall management of this aggressive form of cancer.

Liquid biopsy is a non-invasive diagnostic technique that detects cancer-related genetic mutations and alterations by analyzing circulating tumor DNA (ctDNA) or tumor-derived exosomes in blood samples. In the context of HER-2 Negative Breast Cancer Market, liquid biopsies offer several advantages. They enable real-time monitoring of treatment response, detection of minimal residual disease, and identification of emerging resistance mechanisms. Liquid biopsies also provide an opportunity to identify potential targets for therapeutic intervention, ultimately aiding in personalized treatment decisions.

Next-generation sequencing technologies have revolutionized genomic profiling in HER-2 negative breast cancer. NGS enables comprehensive analysis of tumor genomes, identifying somatic mutations, copy number alterations, and gene expression patterns. By elucidating the genomic landscape of HER-2 negative breast cancer, NGS facilitates the identification of novel therapeutic targets and the development of targeted therapies tailored to individual patients.

AI and ML algorithms have shown remarkable potential in improving the accuracy and efficiency of HER-2 Negative Breast Cancer Market diagnosis, prognosis, and treatment prediction. These technologies can analyze vast amounts of data, including patient records, imaging studies, genomic profiles, and treatment outcomes, to identify patterns, predict response to therapy, and guide treatment decisions. AI and ML algorithms also aid in the development of radiomics, which extract quantitative features from medical images to improve risk stratification and treatment planning.

Immunotherapy has emerged as a promising treatment approach for HER-2 negative breast cancer Market. Immune checkpoint inhibitors, such as PD-1 and PD-L1 inhibitors, have shown efficacy in a subset of patients. The advent of immune profiling technologies, including multiplex immunohistochemistry and high-throughput single-cell RNA sequencing, enables a comprehensive assessment of the tumor microenvironment and the immune response. These technologies aid in identifying potential biomarkers for patient selection, predicting response to immunotherapy, and developing novel immunotherapeutic strategies.

Major Vendors are Pfizer Inc., Novartis AG, Merck & Co. Inc., GSK PLC, AstraZeneca, Eli Lilly and Company, and Bristol-Myers Squibb Company (Celgene Corporation), among others.

Comments

Post a Comment

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

Image
Security Robot Market The Security Robot Market is estimated to be valued at US$ 11.8 billion in 2022 and is expected to exhibit a CAGR of 12.87% over the forecast period of 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Security Robot Market encompasses advanced robotic technologies that are specifically designed and developed to enhance security and surveillance operations. These robots are equipped with features such as video surveillance, thermal imaging, facial recognition, and intrusion detection, among others. They are extensively used by security agencies and organizations across various sectors, including residential, commercial, industrial, and government, to enhance safety, reduce human intervention, and streamline security operations. Security robots offer real-time monitoring, remote control, and high accuracy, making them an ideal choice for surveillance in sensitive areas and remote locations. Market Dynamics:
Read more

Forging has significant application in creation of various metal for wide range of applications

Image
Forging refers to any process that produces metal from scratch by subjecting it to an external force. Metal forgers can be persons or machines. This techniques may involve grinding (for example, to produce alloyed steel) or may involve the application of pressure to apply heat to the metal piece until it is malleable. The actual process depends on various factors, including the material being forged, its shape, and the degree of stress that is placed on it. Forged grain is the product of Forging with grains of metals pushed against each other through a forge-like tool and into the cladding that forms the final shape of the metal after it has been done. It is the principal production process in most metals. It uses local or repetitive thrusts delivered by a hammer or die to apply mechanical blows to the metal piece until it becomes malleable. It is frequently classified according to the speed at which it's done: fast, cold, or hot. There are many types of forgers available today
Read more

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19

Image
Germany Vaccine Contract Manufacturing industry is expected to witness significant growth in the near future, due to emergence of Covid-19. In Germany, from 3 January 2020 to 4:06pm CEST, 18 August 2021, there have been 3,835,375 confirmed cases of COVID-19 with 91,921 deaths, reported to WHO. As of 15 August 2021, a total of 97,884,043 vaccine doses have been administered. The increasing demand for safe and cost-effective vaccines due to unmatchable quality, consistent delivery, and unparalleled security, have contributed to the increasing growth and scope of this industry. The increasing demand for vaccines and resulting profit potential have led to significant growth in the number of contract manufacturing plants located across the world. A major focus of such plants is developing cost effective, high quality vaccines that could be made available to public health organizations and other medical organizations. Several new and innovative technologies are also being developed to man
Read more